Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Dermira Inc Cm ST (DERM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Pacira Pharmaceu has the Best Relative Performance in the Pharmaceuticals Industry (PCRX , OMER , DERM , AERI , OCUL )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

DERM : 10.18 (+1.09%)
PCRX : 37.25 (+0.68%)
OMER : 19.63 (-2.09%)
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Dermira (DERM , TXMD , SUPN , MNK , JNJ )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

DERM : 10.18 (+1.09%)
SUPN : 54.88 (+1.15%)
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with...

DERM : 10.18 (+1.09%)
Dermira Set to Possibly Pullback After Yesterday's Rally of 3.07%

Dermira (NASDAQ:DERM) traded in a range yesterday that spanned from a low of $10.38 to a high of $11.06. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high of $10.43...

DERM : 10.18 (+1.09%)
Dermira (DERM) Gains 5% in a Week, Post-Qbrexa Approval

Shares of Dermira, Inc. (DERM) increase about 5% after the FDA approved its excessive underarm sweating drug, Qbrexza.

AGLE : 9.20 (-1.18%)
DERM : 10.18 (+1.09%)
JAZZ : 176.49 (-0.35%)
ANIP : 70.49 (-0.10%)
Are Options Traders Betting on a Big Move in Dermira (DERM) Stock?

Investors in Dermira (DERM) need to pay close attention to the stock based on moves in the options market lately.

DERM : 10.18 (+1.09%)
SmarTrend Watching for Potential Pullback in Shares of Dermira After 3.64% Gain

Dermira (NASDAQ:DERM) traded in a range yesterday that spanned from a low of $8.96 to a high of $10.89. Yesterday, the shares gained 3.6%, which took the trading range above the 3-day high of $10.72...

DERM : 10.18 (+1.09%)
Thinking about buying stock in Acadia Pharmaceuticals, Camber Energy, Dermira, Nike or Constellation Brands?

InvestorsObserver issues critical PriceWatch Alerts for ACAD, CEI, DERM, NKE, and STZ.

DERM : 10.18 (+1.09%)
CEI : 0.44 (-6.78%)
STZ : 215.96 (+0.06%)
NKE : 76.96 (+0.01%)
ACAD : 16.84 (-1.41%)
Thinking about buying stock in Acadia Pharmaceuticals, Camber Energy, Dermira, Nike or Constellation Brands?

CHICAGO , June 29, 2018 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACAD, CEI, DERM, NKE, and STZ.

DERM : 10.18 (+1.09%)
CEI : 0.44 (-6.78%)
STZ : 215.96 (+0.06%)
NKE : 76.96 (+0.01%)
ACAD : 16.84 (-1.41%)
Dermira Receives FDA Approval for Qbrexza(TM) (glycopyrronium) Cloth to Treat Primary Axillary Hyperhidrosis

-- Qbrexza is the first FDA-approved, once-daily, topical prescription treatment indicated for people with primary axillary hyperhidrosis, also known as excessive underarm sweating

DERM : 10.18 (+1.09%)
Free Daily Technical Summary Reports on Dermira and Three Other Biotech Stocks

Stock Research Monitor: DARE, DRNA, and EGLT

DRNA : 12.53 (-1.34%)
DERM : 10.18 (+1.09%)
DARE : 1.24 (-2.36%)
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with...

DERM : 10.18 (+1.09%)
Investor Expectations to Drive Momentum within Dermira, Atlassian, 51job, Sierra Wireless, Grupo Aeroportuario del Centro Norte S.A.B. de C.V, and InterDigital -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Dermira, Inc. (NASDAQ:DERM),...

DERM : 10.18 (+1.09%)
JOBS : 88.07 (-0.05%)
IDCC : 83.40 (unch)
TEAM : 67.87 (+0.01%)
SWIR : 16.90 (+1.20%)
OMAB : 47.24 (+2.16%)
Dermira, Upcoming FDA Decision on NDA, Analyst Review and Target

NEW YORK, NY / ACCESSWIRE / May 31, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is initiating coverage on Dermira,...

DERM : 10.18 (+1.09%)
Dermira to Present at Jefferies 2018 Global Healthcare Conference

Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with...

DERM : 10.18 (+1.09%)
Therapeuticsmd is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (TXMD , DERM , HZNP , MDCO , SUPN )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

DERM : 10.18 (+1.09%)
HZNP : 17.46 (+0.58%)
Dermira to Host Analyst & Investor Day on May 24, 2018

Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with...

DERM : 10.18 (+1.09%)
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with...

DERM : 10.18 (+1.09%)
Dermira and Cameran Eubanks Team Up to Raise Awareness of Excessive Sweating for the 15 Million People Living with the Condition in the U.S.

Reality television personality Cameran Eubanks and Dermira, Inc. (NASDAQ:DERM) announced today that they are collaborating on a new educational campaign aimed at raising awareness of hyperhidrosis, a medical...

DERM : 10.18 (+1.09%)
Dermira to Present at Deutsche Bank 43rd Annual Healthcare Conference

Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with...

DERM : 10.18 (+1.09%)
DB : 12.03 (+0.08%)

Van Meerten Stock Picks

5 Terrific Mid Caps
In this roller coaster market I wanted to find Mid Cap stocks that had consistent price appreciation over the last 6 month period.
EHC -0.38 , FTNT +0.53 , CAKE -0.45 , PLT -0.28 , AEO -0.65
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures closed the week with most contracts 3 to 4 cents higher on Friday. Nearby September was up 4.1% since last Friday, with higher closes every day this week. Solid exports and drier weather fueled some bottom picking and short covering acti...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar